July 22, 2013

CAS databases provide millions of journal article references from more than 10,000 major scientific journals worldwide, patent and patent family references from 63 patent authorities around the world, and other reputable web sources.

The following patent record is from the CAplusSM database.

CAPLUS COPYRIGHT 2013 ACS

Patent Number: US 8431733
Title: Process for the preparation of (2S,3S)-3-amino-N-cyclopropyl-2-hydroxyalkanamide derivatives in the absence of cyclopropylisonitrile and their use in the synthesis peptidyl HCV and cathepsin inhibitors
Inventor(s): Dener, Jeffrey
Patent Assignee(s): ViroBay, Inc., USA
Source: PCT Int. Appl., 38pp. CODEN: PIXXD2
Language: English

Abstract:
The invention is related to a process for the prepn. of (2S,3S)-3-amino-N-cyclopropyl-2-hydroxyalkanamide derivs. I [R = C1-6 alkyl optionally substituted by C3-6 cycloalkyl] via amidation of acids II with N,O-dimethylhydroxylamine hydrochloride, redn. of the Weinreb amides with LAH, one pot addn. of sodium bisulfite to the aldehydes in an inert org. solvent/treatment of bisulfite adduct with NaCN, conversion of the cyanohydrines III to hydroxyacids IV in the presence of a strong acid, coupling of the acids with cyclopropylamine and debenzylation, and to the use of I in the first step of the synthesis of HCV and cathepsin inhibitors, such as HCV inhibitor V.  The invention allows prepn. of I in the absence of cyclopropylisonitrile via stable, in some steps, solid intermediates which are easily purified by recrystn.  Thus, benzylation of L-norvaline with benzyl bromide in the presence of NaOH/K2CO3 in water, sapon. of the benzyl ester, activation of (S)-2-(dibenzylamino)pentanoic acid with HOBt/EDCI and treatment of the activated acid with N,O-dimethylhydroxylamine hydrochloride in the presence of N-methylmorpholine, redn. of (S)-2-(dibenzylamino)-N-methoxy-N-methylpentanamide with LAH, addn. of sodium bisulfite to (S)-2-(dibenzylamino)pentanal and treatment of the reaction mixt. contg. the bisulfite adduct with NaCN in water, conversion of (2S,3S)-3-(dibenzylamino)-2-hydroxyhexanenitrile to (2S,3S)-3-(dibenzylamino)-2-hydroxyhexanoic acid in the presence of HCl, purifn. of the crude acid via salt formation with ((S)-a-methylbenzyl)amine, amidation of the acid with cyclopropylamine in the presence of HOBt/EDCI and debenzylation by hydrogenolysis gave I [R = Pr-n].  Amidation of (2S,4R)-1-(tert-butoxycarbonyl)-4-[[7-methoxy-2-(1H-pyrazol-1-yl)quinolin-4-yl]oxy]pyrrolidine-2-carboxylic acid with amine I·HCl [R = Pr-n] in the presence of diisopropylethylamine and HATU in CH2Cl2/DMF, cleavage of the tert-butoxycarbonyl group, amidation of (R)-2-(3-tert-butylureido)-3,3-dimethylbutanoic acid with the resulting pyrrolidinium chloride in the presence of diisopropylethylamine and HATU in DMSO and Dess-Martin oxidn. gave peptide deriv. V.

Please note:  Abstracts and Titles for patent records in CAplus are routinely enhanced to better describe the claimed invention.

 View the full-text here.

Recent News

       
    January 26, 2015 | Annual MEDLINE Reload on STN
    Features Enhanced Clinical Trial Information and the
    2015 MeSH Thesaurus
    
    January 23, 2015
 | STN Launches New Pricing
    Option for Information Brokers: Search Service
    Value Pricing
     
    December 19, 2014
| CAS Expands Coverage of
    Reactions from Dissertations in CASREACT
                          
  
                                                                     More News >> 

 Media Contact

 Name: Rhonda Ross
 Phone: 614-447-3624                                       
 Email: cas-pr@cas.org